WCN26-3810 EFFICACY OF DAPTOMYCIN FOR VANCOMYCIN-REFRACTORY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SEPSIS ASSOCIATED WITH VENOUS HYPERTENSION IN VASCULAR ACCESS -A CASE REPORT-

Read full text Summarise with VIRAT
Authors: Fumiya Kitamura, Yukiko Ishiguro, Shinkichi Suzuki, Hiroyuki Ishibashi, Takayuki Katsuno
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Methicillin-resistant staphylococcus aureus (MRSA) is one of the major causes of hospital-acquired infections, and in recent years, its susceptibility to various anti-MRSA drugs has been reported to be declining. Vancomycin (VCM)-resistant MRSA infections are thought to be caused by poor drug penetration into deep tissue infections and resistant strains. Daptomycin (DAP) has strong bactericidal activity and is considered a useful option for treating refractory infections.

Fields of Study & Subjects

Antimicrobial Resistance in Staphylococcus Central Venous Catheters and Hemodialysis Sepsis Diagnosis and Treatment

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105225–105225
Publication date
25 March 2026
Language
EN